Conmed (CNMD) Ratios
Conmed Ratios
MX:CNMD's free cash flow for Q3 2026 was $46.73M. For the 2026 fiscal year, MX:CNMD's free cash flow was decreased by $-2.68M and operating cash flow was $49.41M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.14 | 2.30 | 1.98 | 1.96 | 2.34 |
| Quick Ratio | 1.01 | 1.05 | 0.96 | 0.84 | 1.16 |
| Cash Ratio | 0.13 | 0.09 | 0.08 | 0.10 | 0.11 |
| Solvency Ratio | 0.09 | 0.15 | 0.09 | -0.02 | 0.14 |
| Operating Cash Flow Ratio | 0.54 | 0.60 | 0.40 | 0.11 | 0.57 |
| Short-Term Operating Cash Flow Coverage | 239.73 | 233.52 | 0.00 | 0.48 | 9.12 |
| Net Current Asset Value | $ -619.79M | $ -703.56M | $ -850.15M | $ -970.82M | $ -520.46M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.36 | 0.39 | 0.43 | 0.46 | 0.39 |
| Debt-to-Equity Ratio | 0.81 | 0.94 | 1.19 | 1.41 | 0.87 |
| Debt-to-Capital Ratio | 0.45 | 0.48 | 0.54 | 0.59 | 0.47 |
| Long-Term Debt-to-Capital Ratio | 0.45 | 0.48 | 0.54 | 0.57 | 0.46 |
| Financial Leverage Ratio | 2.25 | 2.40 | 2.76 | 3.08 | 2.25 |
| Debt Service Coverage Ratio | 4.79 | 6.36 | 4.43 | -0.02 | 3.54 |
| Interest Coverage Ratio | 4.54 | 5.37 | 3.03 | 2.42 | 3.09 |
| Debt to Market Cap | 0.66 | 0.43 | 0.29 | 0.40 | 0.17 |
| Interest Debt Per Share | 27.90 | 30.57 | 33.62 | 36.08 | 24.69 |
| Net Debt to EBITDA | 4.50 | 3.24 | 5.02 | 131.56 | 3.70 |
| Profitability Margins | |||||
| Gross Profit Margin | 52.77% | 56.08% | 54.33% | 54.64% | 56.21% |
| EBIT Margin | 7.44% | 15.33% | 9.69% | -4.01% | 10.74% |
| EBITDA Margin | 12.84% | 20.82% | 15.46% | 0.75% | 17.74% |
| Operating Profit Margin | 10.27% | 15.33% | 9.69% | 6.70% | 10.86% |
| Pretax Profit Margin | 5.17% | 12.47% | 6.49% | -6.78% | 7.23% |
| Net Profit Margin | 3.42% | 10.13% | 5.18% | -7.71% | 6.19% |
| Continuous Operations Profit Margin | 3.42% | 10.13% | 5.18% | -7.71% | 6.19% |
| Net Income Per EBT | 66.17% | 81.23% | 79.75% | 113.72% | 85.55% |
| EBT Per EBIT | 50.39% | 81.38% | 67.02% | -101.15% | 66.63% |
| Return on Assets (ROA) | 2.02% | 5.74% | 2.80% | -3.51% | 3.54% |
| Return on Equity (ROE) | 4.55% | 13.76% | 7.73% | -10.81% | 7.96% |
| Return on Capital Employed (ROCE) | 7.02% | 9.88% | 6.06% | 3.50% | 6.99% |
| Return on Invested Capital (ROIC) | 4.64% | 8.02% | 4.81% | 3.38% | 5.93% |
| Return on Tangible Assets | 5.02% | 14.99% | 7.64% | -10.07% | 9.23% |
| Earnings Yield | 3.73% | 6.27% | 1.92% | -3.03% | 1.51% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.55 | 5.50 | 5.14 | 5.46 | 5.50 |
| Payables Turnover | 6.93 | 5.61 | 6.44 | 6.46 | 7.61 |
| Inventory Turnover | 1.83 | 1.66 | 1.79 | 1.43 | 1.91 |
| Fixed Asset Turnover | 12.13 | 11.29 | 10.31 | 9.04 | 9.28 |
| Asset Turnover | 0.59 | 0.57 | 0.54 | 0.46 | 0.57 |
| Working Capital Turnover Ratio | 3.82 | 3.92 | 4.22 | 3.81 | 4.13 |
| Cash Conversion Cycle | 213.08 | 221.85 | 218.78 | 266.09 | 209.45 |
| Days of Sales Outstanding | 65.81 | 66.39 | 71.04 | 66.80 | 66.41 |
| Days of Inventory Outstanding | 199.92 | 220.48 | 204.38 | 255.78 | 191.03 |
| Days of Payables Outstanding | 52.66 | 65.02 | 56.64 | 56.49 | 47.99 |
| Operating Cycle | 265.73 | 286.87 | 275.42 | 322.58 | 257.44 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.50 | 5.41 | 4.09 | 1.11 | 3.83 |
| Free Cash Flow Per Share | 4.86 | 4.99 | 3.47 | 0.39 | 3.32 |
| Dividend Paid and CapEx Coverage Ratio | 3.83 | 4.42 | 2.88 | 0.73 | 2.93 |
| Capital Expenditure Coverage Ratio | 8.62 | 12.76 | 6.59 | 1.53 | 7.52 |
| Operating Cash Flow Coverage Ratio | 0.20 | 0.18 | 0.13 | 0.03 | 0.16 |
| Operating Cash Flow to Sales Ratio | 0.12 | 0.13 | 0.10 | 0.03 | 0.11 |
| Free Cash Flow Yield | 11.97% | 7.29% | 3.17% | 0.43% | 2.34% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 26.71 | 15.94 | 52.10 | -33.04 | 66.10 |
| Price-to-Sales (P/S) Ratio | 0.92 | 1.62 | 2.70 | 2.55 | 4.09 |
| Price-to-Book (P/B) Ratio | 1.22 | 2.19 | 4.03 | 3.57 | 5.26 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 8.35 | 13.72 | 31.59 | 229.94 | 42.66 |
| Price-to-Operating Cash Flow Ratio | 7.38 | 12.64 | 26.79 | 79.81 | 36.99 |
| Price-to-Earnings Growth (PEG) Ratio | -0.41 | 0.15 | -0.29 | 0.15 | 0.12 |
| Enterprise Value Multiple | 11.64 | 10.99 | 22.47 | 473.02 | 26.75 |
| Enterprise Value | 2.05B | 2.99B | 4.33B | 3.69B | 4.80B |
| EV to EBITDA | 11.64 | 10.99 | 22.47 | 473.02 | 26.75 |
| EV to Sales | 1.49 | 2.29 | 3.47 | 3.53 | 4.75 |
| EV to Free Cash Flow | 13.61 | 19.45 | 40.68 | 318.53 | 49.51 |
| EV to Operating Cash Flow | 12.03 | 17.92 | 34.51 | 110.55 | 42.93 |
| Tangible Book Value Per Share | -11.47 | -14.92 | -20.29 | -25.02 | -10.40 |
| Shareholders’ Equity Per Share | 33.29 | 31.21 | 27.20 | 24.82 | 26.93 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.34 | 0.19 | 0.20 | -0.14 | 0.14 |
| Revenue Per Share | 44.29 | 42.37 | 40.59 | 34.80 | 34.66 |
| Net Income Per Share | 1.52 | 4.29 | 2.10 | -2.68 | 2.14 |
| Tax Burden | 0.66 | 0.81 | 0.80 | 1.14 | 0.86 |
| Interest Burden | 0.70 | 0.81 | 0.67 | 1.69 | 0.67 |
| Research & Development to Revenue | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 |
| SG&A to Revenue | 0.38 | 0.37 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Income Quality | 3.63 | 1.26 | 1.94 | -0.41 | 1.79 |
Currency in USD